<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6631207\results\search\tropicalVirus\results.xml">
  <result pre="pmcid: 6631207 doi: 10.3390/ph12020060pharmaceuticals-12-00060 : Review Late Neurological Consequences of" exact="Zika" post="Virus Infection: Risk Factors and Pharmaceutical Approaches SouzaIsis N."/>
  <result pre="of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract" exact="Zika" post="virus (ZIKV) infection was historically considered a disease with"/>
  <result pre="congenitally-exposed babies and in adult patients, have been reported after" exact="ZIKV" post="infection, especially after the 2015 epidemics in the American"/>
  <result pre="that genetic, epigenetic, and environmental factors may contribute to determine" exact="ZIKV" post="infection outcomes. This reinforces the importance that individuals exposed"/>
  <result pre="infection outcomes. This reinforces the importance that individuals exposed to" exact="ZIKV" post="are submitted to long-term clinical surveillance and highlights the"/>
  <result pre="screening pregnancy Food and Drug Administration (FDA) encephalitis 1. Introduction" exact="Zika" post="virus (ZIKV) has been known since 1947 [1], and"/>
  <result pre="in humans. In 2013, this view started to change when" exact="ZIKV" post="occurrence in French Polynesia was associated to development of"/>
  <result pre="It is predicted that over 800,000 people were infected by" exact="ZIKV" post="in the American continent between 2015 and 2018 [2]."/>
  <result pre="Following this epidemic, several studies endorsed a causal relationship between" exact="ZIKV" post="infection and neurological disorders, both in congenitally-exposed newborns and"/>
  <result pre="discuss experimental and clinical evidence of potential therapeutic approaches. 2." exact="ZIKV" post="Infection Is Associated to Late Detrimental Effects to the"/>
  <result pre="neuropathological conditions has been reported in newborn babies exposed to" exact="ZIKV" post="in uterus, being microcephaly the most severe outcome. Infants"/>
  <result pre="focused on unraveling the mechanisms of congenital microcephaly induced by" exact="ZIKV" post="[6,7,8]. However, increasing evidence from clinical and experimental studies"/>
  <result pre="According to US hospital records, 6% of children infected with" exact="ZIKV" post="in uterus showed malformations detectable at birth. Importantly, the"/>
  <result pre="and studies suggest that 60% of normocephalic babies exposed to" exact="ZIKV" post="in uterus present seizures at some stage of development"/>
  <result pre="cerebrospinal fluid space and ventricle enlargement [12]. Infants exposed to" exact="ZIKV" post="during the epidemic in the American continent are still"/>
  <result pre="underlying late ZIKV-induced neurological damage. Using a mouse model of" exact="ZIKV" post="infection, our group was able to predict possible long-term"/>
  <result pre="the second and third trimester of pregnancy [13,14,15], we performed" exact="ZIKV" post="infection shortly after birth (post-natal day 3). Indeed, we"/>
  <result pre="that closely resembled those seen in brains of babies after" exact="ZIKV" post="congenital infection. Over 90% of mice showed spontaneous seizures"/>
  <result pre="episodes resolved when animals became adults, mice infected neonatally with" exact="ZIKV" post="remained more susceptible to chemically-induced seizures. Besides, ZIKV-infected mice"/>
  <result pre="in which authors demonstrated that early-life infection with an African" exact="ZIKV" post="strain results in persistent memory impairments in mice [16]."/>
  <result pre="and decreased hippocampal growth in ZIKV-infected animals. Neurological complications following" exact="ZIKV" post="infection are not limited to cases of congenital infection"/>
  <result pre="cases of congenital infection [18]. Mounting clinical evidence show that" exact="ZIKV" post="infection in adult patients may result in encephalitis [18,19,20],"/>
  <result pre="not yet fully recovered [25]. Collectively, these reports demonstrate that" exact="ZIKV" post="infection is also detrimental to the mature nervous system"/>
  <result pre="mortality. Whether these neurological consequences are a direct effect of" exact="ZIKV" post="replication or are secondary to the host immune response"/>
  <result pre="following sections. Another matter of concern involves the ability of" exact="ZIKV" post="to persist in certain organs and tissues, since the"/>
  <result pre="tissues, since the late consequences of viral persistence remain unknown." exact="ZIKV" post="usually reaches detectable levels in the serum of patients"/>
  <result pre="and up to 200 days after infection, detectable levels of" exact="ZIKV" post="RNA were found in placenta of pregnant women [27]."/>
  <result pre="ZIKV RNA were found in placenta of pregnant women [27]." exact="ZIKV" post="was also shown to persists in semen samples up"/>
  <result pre="of symptoms, reinforcing the high risk of sexual transmission [28,29]." exact="ZIKV" post="RNA was found in brains of babies exposed in"/>
  <result pre="brain of a 5-month-old infected infant [5]. The ability of" exact="ZIKV" post="to replicate for long periods in specific tissues has"/>
  <result pre="found in immunocompetent mice infected during the neonatal period, where" exact="ZIKV" post="negative RNA strand was detectable in the brain into"/>
  <result pre="active viral replication [32]. Altogether, these results provide evidence that" exact="ZIKV" post="is capable of persisting in certain tissues long after"/>
  <result pre="contribute to the development of late neurological damage associated to" exact="ZIKV" post="infection, and what are the precise mechanisms involved. It"/>
  <result pre="is crucial to prevention and treatment of such severe sequelae." exact="ZIKV" post="strains isolated from different geographical regions are derived from"/>
  <result pre="is more cytotoxic and neurovirulent in experimental settings [33,34], the" exact="ZIKV" post="strain responsible for the outbreak in the Americas is"/>
  <result pre="neurovirulence [36]. Interestingly, this substitution emerged in the Southeast Asian" exact="ZIKV" post="strain shortly before the 2013 outbreak and was maintained"/>
  <result pre="in the subsequent epidemics in the Americas [36]. Mutations in" exact="ZIKV" post="genome may also promote host immune system evasion and"/>
  <result pre="the virus. African and Asian populations were highly exposed to" exact="ZIKV" post="historically [39,40,41,42,43], and it has been speculated that prior"/>
  <result pre="or insufficient. While type III IFN response is protective against" exact="ZIKV" post="infection [48], type I response is related to miscarriage"/>
  <result pre="during mid-gestation [49]. Several signaling pathways were shown to modulate" exact="ZIKV" post="infection and individual differences in their expression may confer"/>
  <result pre="differences in their expression may confer variable risk to congenital" exact="Zika" post="syndrome (CZS) and other neurological outcomes: TAM receptors (TYRO3,"/>
  <result pre="TAM receptors (TYRO3, AXL, and MER) are important in mediating" exact="ZIKV" post="persistence through type I IFN downregulation [50,51,52,53,54,55]; toll-like receptors"/>
  <result pre="or concomitant infection by other mosquito-borne viruses is high in" exact="ZIKV" post="endemic regions and co-infections might modulate the hosts’ immune"/>
  <result pre="way [60,61,62,63,64]. Experimental evidence suggest that mosquitoes previously infected with" exact="Chikungunya" post="virus have enhanced ZIKV infectivity and vector competence [65]."/>
  <result pre="suggest that mosquitoes previously infected with Chikungunya virus have enhanced" exact="ZIKV" post="infectivity and vector competence [65]. In line with this,"/>
  <result pre="derived from three independent donors were infected in vitro with" exact="ZIKV" post="(Mexico isolate). The virus was shown to replicate and"/>
  <result pre="were induced from salivary cells obtained from twins exposed to" exact="ZIKV" post="in uterus [67]. Even though the study was performed"/>
  <result pre="derived from CZS-fetuses produced more infectious particles when exposed to" exact="ZIKV" post="in vitro than those from non-CZS infants. RNA sequencing"/>
  <result pre="woman’s individual response to infection influences the efficiency with which" exact="ZIKV" post="crosses the placental barrier. Trophoblasts, placental barrier cells, are"/>
  <result pre="the placental barrier. Trophoblasts, placental barrier cells, are permissive to" exact="ZIKV" post="only during a narrow time-frame, likely in the first"/>
  <result pre="III IFN released could be related to the efficacy of" exact="ZIKV" post="infection in these cells. In addition, other events known"/>
  <result pre="to limit IFN response, like concomitant viral infections, could enhance" exact="ZIKV" post="infectivity. Accordingly, concomitant infection with Herpes Simplex 2 virus"/>
  <result pre="Herpes Simplex 2 virus (HSV-2) increases susceptibility of trophoblasts to" exact="ZIKV" post="[53]. Alternatively, to direct transport, it is possible that"/>
  <result pre="direct transport, it is possible that maternal antibody-mediated transcytosis drives" exact="ZIKV" post="transportation across the placental barrier. Indeed, experimental evidence has"/>
  <result pre="the placental barrier. Indeed, experimental evidence has shown that placental" exact="ZIKV" post="replication is enhanced by previous infection with Dengue virus"/>
  <result pre="that placental ZIKV replication is enhanced by previous infection with" exact="Dengue" post="virus [60,71]. In addition to trophoblasts, placenta villous macrophages"/>
  <result pre="placenta villous macrophages (Hofbauer cells) and fibroblasts are susceptible to" exact="ZIKV" post="infection [68,72]. When exposed to ZIKV, Hofbauer cells become"/>
  <result pre="that the intensity of placental immune response influences how much" exact="ZIKV" post="actually reach the fetus [68]. Despite factors specific to"/>
  <result pre="other factors can have contributed to the unforeseen scale of" exact="ZIKV" post="neurological damage seen in recent years. An interesting study"/>
  <result pre="study in immunodeficient mice has suggested that sexual transmission of" exact="ZIKV" post="favors congenital infection and the development of malformations of"/>
  <result pre="may also play a role in the severity of congenital" exact="ZIKV" post="syndrome [73]. As recently reviewed by Barbeito-Andrés and colleagues"/>
  <result pre="neurological outcome of infection. In Brazil, although the incidence of" exact="ZIKV" post="infection was similar in all regions in 2015, congenital"/>
  <result pre="ZIKV infection was similar in all regions in 2015, congenital" exact="ZIKV" post="syndrome was significantly higher in the northeast region, a"/>
  <result pre="to determine the higher rate of neurological complications due to" exact="ZIKV" post="infection in specific geographical regions. 4. Promising Therapeutic Approaches"/>
  <result pre="Similar to other mosquito-borne diseases, clinical management of patients with" exact="ZIKV" post="infection is largely based on alleviating symptoms of the"/>
  <result pre="on testing prophylactic drugs and creating vaccines to prevent new" exact="ZIKV" post="epidemics. Nevertheless, some effort has also been directed to"/>
  <result pre="development, which have shown promising results in different models of" exact="ZIKV" post="infection. These substances act either during acute stages of"/>
  <result pre="or have shown potential to prevent the late complications of" exact="ZIKV" post="infection (Table 1 and Supplementary Figure S1). 5. Antiviral"/>
  <result pre="prodrug clinically used against hepatitis C virus (HCV), to inhibit" exact="ZIKV" post="replication [100,101]. Later, two independent groups published experimental evidence"/>
  <result pre="effectively inhibited infection and replication by both African and American" exact="ZIKV" post="strains in different in vitro models: placental and neuroblastoma"/>
  <result pre="of viral genetic mutations, indicating a possible secondary mechanism of" exact="ZIKV" post="replication blockage. Experiments performed in animal models also showed"/>
  <result pre="synergic antiviral activity was observed against several different strains of" exact="ZIKV" post="[105], proving that a combination strategy might be beneficial."/>
  <result pre="Although mathematical modeling indicated that the expected dose needed for" exact="ZIKV" post="inhibition would be twice the therapeutic dose used for"/>
  <result pre="Favipiravir Another RNA polymerase inhibitor that has been proposed as" exact="ZIKV" post="therapeutic is favipiravir (FAV; T-705). Early reports indicated its"/>
  <result pre="T-705). Early reports indicated its ability to inhibit seven different" exact="ZIKV" post="strains in preliminary tests in vitro [88,89]. Conflicting results,"/>
  <result pre="were found in studies designed to evaluate whether FAV inhibits" exact="ZIKV" post="replication in more complex models. While one group reported"/>
  <result pre="[90], another study showed that FAV induced efficient reduction in" exact="ZIKV" post="protein expression in human neural progenitor cells derived from"/>
  <result pre="derivation. FAV has been shown to cause significant mutation in" exact="ZIKV" post="genome, indicating yet another possible mechanism for its antiviral"/>
  <result pre="of cytotoxicity in Vero cells [110]. In silico models of" exact="ZIKV" post="infection using non-human primate pharmacokinetic parameters, indicate that 150"/>
  <result pre="a strong candidate for further pre-clinical and clinical testing for" exact="ZIKV" post="treatment. Furthermore, its analog, T-1105, has also presented antiviral"/>
  <result pre="its analog, T-1105, has also presented antiviral activity against SZ01" exact="ZIKV" post="strain [89], indicating it might be a good scaffold"/>
  <result pre="RNA copies in the brain and reduced monocyte infiltration following" exact="ZIKV" post="infection [83]. AZT is an FDA category B drug,"/>
  <result pre="considerably low cost makes AZT an interesting candidate for post-exposure" exact="ZIKV" post="treatment. No studies so far have investigated the precise"/>
  <result pre="lacking interferon-mediated immune response (IFN-α/βR−/− mice) infected with the Brazilian" exact="ZIKV" post="strain: daily oral treatment with 30 mg/kg of ME"/>
  <result pre="[117]. Further studies are necessary to determine its efficacy in" exact="ZIKV" post="management in other animal models and in human subjects."/>
  <result pre="the extensive pro-inflammatory profile of brain tissue during and after" exact="ZIKV" post="infection, anti-inflammatory therapy might be of help to alleviate"/>
  <result pre="(IFX) (20 μg/day) is able to prevent long-term consequences of" exact="ZIKV" post="infection in neonatal (post-natal day 3) Swiss mice [32]."/>
  <result pre="that is currently considered a potential drug candidate to treat" exact="ZIKV" post="infection. PHA showed antiviral activity against two different ZIKV"/>
  <result pre="treat ZIKV infection. PHA showed antiviral activity against two different" exact="ZIKV" post="strains in human astrocytes derived from iPSCs and human"/>
  <result pre="also tested, nine of which presented submicromolar IC50 concentrations against" exact="ZIKV" post="replication in culture. These findings open new avenues for"/>
  <result pre="viability of human astrocytes and hNPCs infected with several different" exact="ZIKV" post="strains [87]. This strong neuroprotective effect was not due"/>
  <result pre="significantly improving cell viability of human astrocyte cultures exposed to" exact="ZIKV" post="when compared to the effects of both isolated substances."/>
  <result pre="consequences of HCV infection [120], being a good candidate for" exact="ZIKV" post="management, especially in combination with other drugs. 6.5. Niclosamide"/>
  <result pre="there might be other mechanisms by which the drug mitigates" exact="ZIKV" post="infection. Several groups have developed innovative formulations in order"/>
  <result pre="and colleagues tested CQ against African and Brazilian strains of" exact="ZIKV" post="in human neural progenitor cells, human brain microvascular endothelial"/>
  <result pre="2016). CQ also reduced mortality and weight loss caused by" exact="ZIKV" post="infection in adult AG129 mice, when administered in drinking"/>
  <result pre="(AQ). A high-content screening study identified its ability to prevent" exact="ZIKV" post="infection and its toxicity in human pluripotent stem cell-derived"/>
  <result pre="showed comparable results to CQ when tested against Asian PLCal_ZV" exact="ZIKV" post="strain in Vero cells [81]. In an adult immunodeficient"/>
  <result pre="of treatment with AQ (40 mg/kg/day s.c.) led to lower" exact="ZIKV" post="RNA levels and decreased levels of ZIKV E-protein in"/>
  <result pre="led to lower ZIKV RNA levels and decreased levels of" exact="ZIKV" post="E-protein in the brain [80]. Three AQ derivatives, quinacrine,"/>
  <result pre="to Vero cells infected separately with two different strains of" exact="ZIKV" post="[96,97]. Previous reports had already indicated that NITD008 has"/>
  <result pre="others viruses in previous studies, and was recently tested against" exact="ZIKV" post="[133]. It was able to reduce cytopathic effect and"/>
  <result pre="and RD cell lines infected with African, Asian, or American" exact="ZIKV" post="strains [92]. Furthermore, in a model of lethal infection"/>
  <result pre="report, RIB was able to inhibit replication of several different" exact="ZIKV" post="strains in vitro [88]. Such result was confirmed by"/>
  <result pre="Therefore, its use might be limited to severe consequences of" exact="ZIKV" post="infection exclusively in otherwise healthy adults. 6.11. Other Reported"/>
  <result pre="is a synthetic peptide derived from the stem region of" exact="ZIKV" post="envelope protein which showed potent anti-ZIKV activity. Z2 was"/>
  <result pre="was able to inhibit infection and diminish cytotoxic effects of" exact="ZIKV" post="on Vero and BHK21 cells. In pregnant ICR mice,"/>
  <result pre="up to 120 mg/kg. It also blocked vertical transmission of" exact="ZIKV" post="in this same mouse model at 10 mg/kg i.v."/>
  <result pre="development. Finally, a single study proposed natural products as possible" exact="ZIKV" post="inhibitors. The flavonoids Myricetin and Quercetin were able to"/>
  <result pre="The flavonoids Myricetin and Quercetin were able to inhibit the" exact="ZIKV" post="NS2B-NS3 pro protein complex with sub- and micromolar concentrations"/>
  <result pre="Conclusions The unprecedented high number of neurological symptoms associated to" exact="ZIKV" post="infection after its landing in the Americas in 2015"/>
  <result pre="social consequences that cannot be fully estimated. The observation that" exact="ZIKV" post="infection leads to late neurological burden both in congenitally-exposed"/>
  <result pre="have gathered efforts in order to identify the mechanisms underlying" exact="ZIKV" post="neurotoxicity and to search for drug candidates that can"/>
  <result pre="polymerase inhibitors and several antimalarial quinines have been tested against" exact="ZIKV" post="replication and its neurological damage. However, despite the promising"/>
  <result pre="vitro results, none of them has reached clinical trials for" exact="ZIKV" post="infection yet. In silico drug design should also be"/>
  <result pre="are available online at https://www.mdpi.com/1424-8247/12/2/60/s1, Figure S1: Possible candidates for" exact="ZIKV" post="infection treatment. These drugs, either repurposed or under development,"/>
  <result pre="repurposed or under development, have shown promising results in treating" exact="ZIKV" post="infection in both adult and vertical transmission or neonatal"/>
  <result pre="Med. Hyg.19524650952010.1016/0035-9203(52)90042-412995440 2.collab: PAHO/WHOZika Cases and Congenital Syndrome Associated with" exact="Zika" post="Virus Reported by Countries and Territories in the Americas"/>
  <result pre="al.Early Growth and Neurologic Outcomes of Infants with Probable Congenital" exact="Zika" post="Virus SyndromeEmerg. Infect. Dis.2016221953195610.3201/eid2211.16095627767931 4.CarvalhoM.D.C.G.de Miranda-FilhoD.B.van der LindenV.SobralP.F.RamosR.C.F.RochaM.Â.W.CordeiroM.T.de AlencarS.P.NunesM.L.Sleep"/>
  <result pre="Miranda-FilhoD.B.van der LindenV.SobralP.F.RamosR.C.F.RochaM.Â.W.CordeiroM.T.de AlencarS.P.NunesM.L.Sleep EEG patterns in infants with congenital" exact="Zika" post="virus syndromeClin. Neurophysiol.201712820421410.1016/j.clinph.2016.11.00427923187 5.ChimelliL.PoneS.M.Avvad-PortariE.VasconcelosZ.F.M.ZinA.A.CunhaD.P.ThompsonN.R.MoreiraM.E.L.WileyC.A.da PoneM.V.S.Persistence of Zika virus after"/>
  <result pre="infants with congenital Zika virus syndromeClin. Neurophysiol.201712820421410.1016/j.clinph.2016.11.00427923187 5.ChimelliL.PoneS.M.Avvad-PortariE.VasconcelosZ.F.M.ZinA.A.CunhaD.P.ThompsonN.R.MoreiraM.E.L.WileyC.A.da PoneM.V.S.Persistence of" exact="Zika" post="virus after birth: Clinical, virological, neuroimaging, and neuropathological documentation"/>
  <result pre="neuroimaging, and neuropathological documentation in a 5-month infant with congenital" exact="Zika" post="syndromeJ. Neuropathol. Exp. Neurol.20187719319810.1093/jnen/nlx11629346650 6.CugolaF.R.FernandesI.R.RussoF.B.FreitasB.C.DiasJ.L.M.GuimarãesK.P.BenazzatoC.AlmeidaN.PignatariG.C.RomeroS.et al.The Brazilian Zika virus"/>
  <result pre="with congenital Zika syndromeJ. Neuropathol. Exp. Neurol.20187719319810.1093/jnen/nlx11629346650 6.CugolaF.R.FernandesI.R.RussoF.B.FreitasB.C.DiasJ.L.M.GuimarãesK.P.BenazzatoC.AlmeidaN.PignatariG.C.RomeroS.et al.The Brazilian" exact="Zika" post="virus strain causes birth defects in experimental modelsNature201653426727110.1038/nature1829627279226 7.van"/>
  <result pre="Virus Targeting in the Developing BrainJ. Neurosci.2017372161217510.1523/JNEUROSCI.3124-16.201728123079 8.WuK.-Y.ZuoG.-L.LiX.-F.YeQ.DengY.-Q.HuangX.-Y.CaoW.-C.QinC.-F.LuoZ.-G.Vertical transmission of" exact="Zika" post="virus targeting the radial glial cells affects cortex development"/>
  <result pre="Zika-Associated Birth Defects and Neurodevelopmental Abnormalities Possibly Associated with Congenital" exact="Zika" post="Virus Infection—U.S. Territories and Freely Associated States, 2018Morb. Mortal."/>
  <result pre="of 13 Infants Born During October 2015–January 2016 With Congenital" exact="Zika" post="Virus Infection Without Microcephaly at Birth—BrazilMMWR. Morb. Mortal. Wkly."/>
  <result pre="Microcephaly at Birth—BrazilMMWR. Morb. Mortal. Wkly. Rep.2016651343134810.15585/mmwr.mm6547e227906905 12.Prata-BarbosaA.MartinsM.M.GuastavinoA.B.da CunhaA.J.L.A.Effects of" exact="Zika" post="infection on growthJ. Pediatr (Rio J)201810.1016/j.jped.2018.10.016 13.SempleB.D.BlomgrenK.GimlinK.FerrieroD.M.Noble-HaeussleinL.J.Brain development in"/>
  <result pre="betterFront. Behav. Neurosci.2015926510.3389/fnbeh.2015.0026526500515 16.FerreiraA.C.Zaverucha-do-ValleC.ReisP.A.Barbosa-LimaG.VieiraY.R.MattosM.de SilvaP.SacramentoC.de Castro Faria NetoH.C.CampanatiL.et al.Sofosbuvir protects" exact="Zika" post="virus-infected mice from mortality, preventing short- and long-term sequelaeSci."/>
  <result pre="from mortality, preventing short- and long-term sequelaeSci. Rep.20177940910.1038/s41598-017-09797-828842610 17.MavignerM.RaperJ.Kovacs-BalintZ.GumberS.O’NealJ.T.BhaumikS.K.ZhangX.HabibJ.MattinglyC.McDonaldC.E.et al.Postnatal" exact="Zika" post="virus infection is associated with persistent abnormalities in brain"/>
  <result pre="Transl. Med.201810eaao697510.1126/scitranslmed.aao697529618564 18.da SilvaI.R.F.FronteraJ.A.de FilippisA.M.B.do NascimentoO.J.M.Neurologic Complications Associated With the" exact="Zika" post="Virus in Brazilian AdultsJAMA Neurol.2017741190119810.1001/jamaneurol.2017.170328806453 19.MuñozL.S.BarrerasP.PardoC.A.Zika Virus-Associated Neurological Disease"/>
  <result pre="MachadoM.�?.Henriques-SouzaA.CordeiroM.T.de MarquesE.T.PenaL.J.Guillain-Barré Syndrome, Acute Disseminated Encephalomyelitis and Encephalitis Associated with" exact="Zika" post="Virus Infection in Brazil: Detection of Viral RNA and"/>
  <result pre="Crit. Care20174227528110.1016/j.jcrc.2017.07.03828806562 22.WillisonH.JacobsB.van DoornP.Guillain-Barré SyndromeLancet2016231295130910.1016/S0140-6736(16)00339-1 23.ParraB.LizarazoJ.Jiménez-ArangoJ.A.Zea-VeraA.F.González-ManriqueG.VargasJ.AngaritaJ.A.ZuñigaG.Lopez-GonzalezR.BeltranC.L.et al.Guillain–Barré Syndrome Associated with" exact="Zika" post="Virus Infection in ColombiaN. Engl. J. Med.20163751513152310.1056/NEJMoa160556427705091 24.AzevedoR.S.S.AraujoM.T.Martins FilhoA.J.OliveiraC.S.NunesB.T.D.CruzA.C.R.NascimentoA.G.P.A.C.MedeirosR.C.CaldasC.A.M.AraujoF.C.et"/>
  <result pre="Zika-associated Guillain-Barré syndromeEmerg. Microbes Infect.201874710.1038/s41426-018-0151-929323108 26.LanciottiR.S.KosoyO.L.LavenJ.J.VelezJ.O.LambertA.J.JohnsonA.J.StanfieldS.M.DuffyM.R.Genetic and serologic properties of" exact="Zika" post="virus associated with an epidemic, Yap State, Micronesia, 2007Emerg."/>
  <result pre="Infect. Dis.20172340541410.3201/eid2303.16149927959260 28.MedinaF.A.TorresG.AcevedoJ.FonsecaS.CasianoL.De León-RodríguezC.M.SantiagoG.A.DoyleK.SharpT.M.AlvaradoL.I.et al.Duration of the Presence of Infectious" exact="Zika" post="Virus in Semen and SerumJ. Infect. Dis.2018219314010.1093/infdis/jiy462 29.Oliveira SoutoI.Alejo-CanchoI.Gascón"/>
  <result pre="SerumJ. Infect. Dis.2018219314010.1093/infdis/jiy462 29.Oliveira SoutoI.Alejo-CanchoI.Gascón BrustengaJ.Peiró MestresA.Muñoz GutiérrezJ.Martínez YoldiM.J.Persistence of" exact="Zika" post="virus in semen 93 days after the onset of"/>
  <result pre="tissuesPLoS Pathog.201713e100621910.1371/journal.ppat.100621928278237 32.SouzaI.N.O.FrostP.S.FrançaJ.V.Nascimento-VianaJ.B.NerisR.L.S.FreitasL.PinheiroD.J.L.L.NogueiraC.O.NevesG.ChimelliL.et al.Acute and chronic neurological consequences of early-life" exact="Zika" post="virus infection in miceSci. Transl. Med.201810eaar274910.1126/scitranslmed.aar274929875203 33.SimoninY.LoustalotF.DesmetzC.FoulongneV.ConstantO.Fournier-WirthC.LeonF.MolèsJ.-P.GoubaudA.LemaitreJ.-M.et al.Zika Virus"/>
  <result pre="Display Different Infectious Profiles in Human Neural CellsEBioMedicine20161216116910.1016/j.ebiom.2016.09.02027688094 34.ShaoQ.HerrlingerS.ZhuY.-N.YangM.GoodfellowF.SticeS.L.QiX.-P.BrindleyM.A.ChenJ.-F.The African" exact="Zika" post="virus MR-766 is more virulent and causes more severe"/>
  <result pre="virusDevelopment20171444114412410.1242/dev.15675228993398 35.CalvetG.AguiarR.S.MeloA.S.O.SampaioS.A.de FilippisI.FabriA.AraujoE.S.M.de SequeiraP.C.de MendonçaM.C.L.de OliveiraL.et al.Detection and sequencing of" exact="Zika" post="virus from amniotic fl uid of fetuses with microcephaly"/>
  <result pre="Dis20161665366010.1016/S1473-3099(16)00095-526897108 36.YuanL.HuangX.-Y.LiuZ.-Y.ZhangF.ZhuX.-L.YuJ.-Y.JiX.XuY.-P.LiG.LiC.et al.A single mutation in the prM protein of" exact="Zika" post="virus contributes to fetal microcephalyScience201735893393610.1126/science.aam712028971967 37.LiuY.LiuJ.DuS.ShanC.NieK.ZhangR.LiX.-F.ZhangR.WangT.QinC.-F.et al.Evolutionary enhancement of"/>
  <result pre="Zika virus contributes to fetal microcephalyScience201735893393610.1126/science.aam712028971967 37.LiuY.LiuJ.DuS.ShanC.NieK.ZhangR.LiX.-F.ZhangR.WangT.QinC.-F.et al.Evolutionary enhancement of" exact="Zika" post="virus infectivity in Aedes aegypti mosquitoesNature201754548210.1038/nature2236528514450 38.XiaH.LuoH.ShanC.MuruatoA.E.NunesB.T.D.MedeirosD.B.A.ZouJ.XieX.GiraldoM.I.VasconcelosP.F.C.et al.An evolutionary"/>
  <result pre="in Aedes aegypti mosquitoesNature201754548210.1038/nature2236528514450 38.XiaH.LuoH.ShanC.MuruatoA.E.NunesB.T.D.MedeirosD.B.A.ZouJ.XieX.GiraldoM.I.VasconcelosP.F.C.et al.An evolutionary NS1 mutation enhances" exact="Zika" post="virus evasion of host interferon inductionNat. Commun.2018941410.1038/s41467-017-02816-229379028 39.Adekolu-JohnE.O.FagbamiA.H.Arthropod-borne virus"/>
  <result pre="Brain and Alters ProliferationCell Stem Cell20161959359810.1016/j.stem.2016.08.00527545505 46.LazearH.M.GoveroJ.SmithA.M.PlattD.J.FernandezE.MinerJ.J.DiamondM.S.A Mouse Model of" exact="Zika" post="Virus PathogenesisCell Host Microbe20161972073010.1016/j.chom.2016.03.01027066744 47.SmithD.R.HollidgeB.DayeS.ZengX.BlancettC.KuszpitK.BocanT.KoehlerJ.W.CoyneS.MinogueT.et al.Neuropathogenesis of Zika Virus"/>
  <result pre="Model of Zika Virus PathogenesisCell Host Microbe20161972073010.1016/j.chom.2016.03.01027066744 47.SmithD.R.HollidgeB.DayeS.ZengX.BlancettC.KuszpitK.BocanT.KoehlerJ.W.CoyneS.MinogueT.et al.Neuropathogenesis of" exact="Zika" post="Virus in a Highly Susceptible Immunocompetent Mouse Model after"/>
  <result pre="III Interferons Produced by Human Placental Trophoblasts Confer Protection against" exact="Zika" post="Virus InfectionCell Host Microbe20161970571210.1016/j.chom.2016.03.00827066743 49.YockeyL.J.JuradoK.A.AroraN.MilletA.RakibT.MilanoK.M.HastingsA.K.FikrigE.KongY.HorvathT.L.et al.Type I interferons instigate"/>
  <result pre="Host Microbe20161970571210.1016/j.chom.2016.03.00827066743 49.YockeyL.J.JuradoK.A.AroraN.MilletA.RakibT.MilanoK.M.HastingsA.K.FikrigE.KongY.HorvathT.L.et al.Type I interferons instigate fetal demise after" exact="Zika" post="virus infectionSci. Immunol.20183eaao1680b10.1126/sciimmunol.aao168029305462 50.OjhaC.R.RodriguezM.KaruppanM.K.M.LapierreJ.KashanchiF.El-HageN.Toll-like receptor 3 regulates Zika virus"/>
  <result pre="demise after Zika virus infectionSci. Immunol.20183eaao1680b10.1126/sciimmunol.aao168029305462 50.OjhaC.R.RodriguezM.KaruppanM.K.M.LapierreJ.KashanchiF.El-HageN.Toll-like receptor 3 regulates" exact="Zika" post="virus infection and associated host inflammatory response in primary"/>
  <result pre="Not Protect Human Neural Progenitor Cells and Cerebral Organoids from" exact="Zika" post="Virus InfectionCell Stem Cell20161970370810.1016/j.stem.2016.11.01127912091 52.LimontaD.JovelJ.KumarA.AiroA.M.HouS.SaitoL.BrantonW.Ka-Shu WongG.MasonA.PowerC.et al.Human Fetal Astrocytes"/>
  <result pre="InfectionCell Stem Cell20161970370810.1016/j.stem.2016.11.01127912091 52.LimontaD.JovelJ.KumarA.AiroA.M.HouS.SaitoL.BrantonW.Ka-Shu WongG.MasonA.PowerC.et al.Human Fetal Astrocytes Infected with" exact="Zika" post="Virus Exhibit Delayed Apoptosis and Resistance to Interferon: Implications"/>
  <result pre="Apoptosis and Resistance to Interferon: Implications for PersistenceViruses20181064610.3390/v1011064630453621 53.AldoP.YouY.SzigetiK.HorvathT.L.LindenbachB.MorG.HSV-2 enhances" exact="ZIKV" post="infection of the placenta and induces apoptosis in first-trimester"/>
  <result pre="J. Reprod. Immunol.20167634835710.1111/aji.1257827613665 54.HastingsA.K.YockeyL.J.JaggerB.W.HwangJ.UrakiR.GaitschH.F.ParnellL.A.CaoB.MysorekarI.U.RothlinC.V.et al.TAM Receptors Are Not Required for" exact="Zika" post="Virus Infection in MiceCell Rep.20171955856810.1016/j.celrep.2017.03.05828423319 55.ChenJ.YangY.YangY.ZouP.ChenJ.HeY.ShuiS.CuiY.BaiR.LiangY.et al.AXL promotes Zika"/>
  <result pre="for Zika Virus Infection in MiceCell Rep.20171955856810.1016/j.celrep.2017.03.05828423319 55.ChenJ.YangY.YangY.ZouP.ChenJ.HeY.ShuiS.CuiY.BaiR.LiangY.et al.AXL promotes" exact="Zika" post="virus infection in astrocytes by antagonizing type I interferon"/>
  <result pre="antagonizing type I interferon signallingNat. Microbiol.2018330230910.1038/s41564-017-0092-429379210 56.LiuY.Gordesky-GoldB.Leney-GreeneM.WeinbrenN.L.TudorM.CherryS.Inflammation-Induced, STING-Dependent Autophagy Restricts" exact="Zika" post="Virus Infection in the Drosophila BrainCell Host Microbe201824576810.1016/j.chom.2018.05.02229934091 57.ChiramelA.I.BestS.M.Role"/>
  <result pre="in the Drosophila BrainCell Host Microbe201824576810.1016/j.chom.2018.05.02229934091 57.ChiramelA.I.BestS.M.Role of autophagy in" exact="Zika" post="virus infection and pathogenesisVirus Res.2018254344010.1016/j.virusres.2017.09.00628899653 58.DelgadoF.G.TorresK.I.CastellanosJ.E.Romero-SánchezC.Simon-LorièreE.SakuntabhaiA.RothC.Improved Immune Responses Against"/>
  <result pre="Zika virus infection and pathogenesisVirus Res.2018254344010.1016/j.virusres.2017.09.00628899653 58.DelgadoF.G.TorresK.I.CastellanosJ.E.Romero-SánchezC.Simon-LorièreE.SakuntabhaiA.RothC.Improved Immune Responses Against" exact="Zika" post="Virus After Sequential Dengue and Zika Virus Infection in"/>
  <result pre="pathogenesisVirus Res.2018254344010.1016/j.virusres.2017.09.00628899653 58.DelgadoF.G.TorresK.I.CastellanosJ.E.Romero-SánchezC.Simon-LorièreE.SakuntabhaiA.RothC.Improved Immune Responses Against Zika Virus After Sequential" exact="Dengue" post="and Zika Virus Infection in HumansViruses20181048010.3390/v10090480 59.WenJ.Elong NgonoA.Regla-NavaJ.A.KimK.GormanM.J.DiamondM.S.ShrestaS.Dengue virus-reactive"/>
  <result pre="58.DelgadoF.G.TorresK.I.CastellanosJ.E.Romero-SánchezC.Simon-LorièreE.SakuntabhaiA.RothC.Improved Immune Responses Against Zika Virus After Sequential Dengue and" exact="Zika" post="Virus Infection in HumansViruses20181048010.3390/v10090480 59.WenJ.Elong NgonoA.Regla-NavaJ.A.KimK.GormanM.J.DiamondM.S.ShrestaS.Dengue virus-reactive CD8+ T"/>
  <result pre="59.WenJ.Elong NgonoA.Regla-NavaJ.A.KimK.GormanM.J.DiamondM.S.ShrestaS.Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent" exact="Zika" post="virus challengeNat. Commun.20178145910.1038/s41467-017-01669-z29129917 60.BrownJ.A.SinghG.AcklinJ.A.LeeS.DuehrJ.E.ChokolaA.N.FrereJ.J.HoffmanK.W.FosterG.A.KrysztofD.et al.Dengue Virus Immunity Increases Zika"/>
  <result pre="subsequent Zika virus challengeNat. Commun.20178145910.1038/s41467-017-01669-z29129917 60.BrownJ.A.SinghG.AcklinJ.A.LeeS.DuehrJ.E.ChokolaA.N.FrereJ.J.HoffmanK.W.FosterG.A.KrysztofD.et al.Dengue Virus Immunity Increases" exact="Zika" post="Virus-Induced Damage during PregnancyImmunity201910.1016/j.immuni.2019.01.005 61.BardinaS.V.BunducP.TripathiS.DuehrJ.FrereJ.J.BrownJ.A.NachbagauerR.FosterG.A.KrysztofD.TortorellaD.et al.Enhancement of Zika virus"/>
  <result pre="Immunity Increases Zika Virus-Induced Damage during PregnancyImmunity201910.1016/j.immuni.2019.01.005 61.BardinaS.V.BunducP.TripathiS.DuehrJ.FrereJ.J.BrownJ.A.NachbagauerR.FosterG.A.KrysztofD.TortorellaD.et al.Enhancement of" exact="Zika" post="virus pathogenesis by preexisting antiflavivirus immunityScience201735617518010.1126/science.aal436528360135 62.DejnirattisaiW.SupasaP.WongwiwatW.RouvinskiA.Barba-SpaethG.DuangchindaT.SakuntabhaiA.Cao-LormeauV.-M.MalasitP.ReyF.A.et al.Dengue virus"/>
  <result pre="infection with zika virusNat. Immunol.2016171102110810.1038/ni.351527339099 63.De AraújoP.S.R.de Silva JúniorM.L.Jr.TenórioM.dos SantosF.G.T.Co-infection" exact="ZIKV" post="and HSV-1 associated with meningoencephalitis: Case report and literature"/>
  <result pre="Infect. Dis.201719e1270010.1111/tid.12700 65.MagalhaesT.RobisonA.YoungM.BlackW.FoyB.EbelG.RückertC.MagalhaesT.RobisonA.YoungM.C.et al.Sequential Infection of Aedes aegypti Mosquitoes with" exact="Chikungunya" post="Virus and Zika Virus Enhances Early Zika Virus TransmissionInsects2018917710.3390/insects904017730513725"/>
  <result pre="al.Sequential Infection of Aedes aegypti Mosquitoes with Chikungunya Virus and" exact="Zika" post="Virus Enhances Early Zika Virus TransmissionInsects2018917710.3390/insects904017730513725 66.McgrathE.L.RossiS.L.GaoJ.WidenS.G.GrantA.C.DunnT.J.AzarS.R.RoundyC.M.XiongY.PrusakD.J.et al.Differential Responses"/>
  <result pre="aegypti Mosquitoes with Chikungunya Virus and Zika Virus Enhances Early" exact="Zika" post="Virus TransmissionInsects2018917710.3390/insects904017730513725 66.McgrathE.L.RossiS.L.GaoJ.WidenS.G.GrantA.C.DunnT.J.AzarS.R.RoundyC.M.XiongY.PrusakD.J.et al.Differential Responses of Human Fetal Brain"/>
  <result pre="al.Differential Responses of Human Fetal Brain Neural Stem Cells to" exact="Zika" post="Virus InfectionStem Cell Rep.2017871572710.1016/j.stemcr.2017.01.00828216147 67.Caires-JuniorL.C.GoulartE.MeloU.S.AraujoB.H.S.AlviziL.Soares-SchanoskiA.de OliveiraD.F.KobayashiG.S.Griesi-OliveiraK.MussoC.M.et al.Discordant congenital Zika"/>
  <result pre="to Zika Virus InfectionStem Cell Rep.2017871572710.1016/j.stemcr.2017.01.00828216147 67.Caires-JuniorL.C.GoulartE.MeloU.S.AraujoB.H.S.AlviziL.Soares-SchanoskiA.de OliveiraD.F.KobayashiG.S.Griesi-OliveiraK.MussoC.M.et al.Discordant congenital" exact="Zika" post="syndrome twins show differential in vitro viral susceptibility of"/>
  <result pre="Placenta-Fetus Model Demonstrating Maternal–Fetal Transmission and Fetal Neural Toxicity of" exact="Zika" post="VirusAnn. Biomed. Eng.2018461963197410.1007/s10439-018-2090-y30003503 70.RibeiroM.R.MoreliJ.B.MarquesR.E.PapaM.P.MeurenL.M.RahalP.de ArrudaL.B.OlianiA.H.OlianiD.C.M.V.OlianiS.M.et al.Zika-virus-infected human full-term placental"/>
  <result pre="productively infects primary human placenta-specific macrophagesJCI Insight20161e8846110.1172/jci.insight.8846127595140 73.DuggalN.K.McdonaldE.M.RitterJ.M.BraultA.C.Sexual transmission of" exact="Zika" post="virus enhances in utero transmission in a mouse model"/>
  <result pre="transmission in a mouse model OPENSci. Rep.20188451010.1038/s41598-018-22840-629540804 74.Barbeito-AndrésJ.Schuler-FacciniL.GarcezP.P.Why is congenital" exact="Zika" post="syndrome asymmetrically distributed among human populations?PLoS Biol.201816e200659210.1371/journal.pbio.200659230142150 75.de OliveiraW.K.de"/>
  <result pre="OliveiraW.K.de FrançaG.V.A.CarmoE.H.DuncanB.B.de Souza KuchenbeckerR.SchmidtM.I.Infection-related microcephaly after the 2015 and 2016" exact="Zika" post="virus outbreaks in Brazil: A surveillance-based analysisLancet201739086187010.1016/S0140-6736(17)31368-528647172 76.SouzaA.I.de SiqueiraM.T.FerreiraA.L.C.G.de"/>
  <result pre="A surveillance-based analysisLancet201739086187010.1016/S0140-6736(17)31368-528647172 76.SouzaA.I.de SiqueiraM.T.FerreiraA.L.C.G.de FreitasC.U.BezerraE.V.RibeiroA.G.NardocciA.C.Geography of Microcephaly in the" exact="Zika" post="Era: A Study of Newborn Distribution and Socio-environmental Indicators"/>
  <result pre="Brazil, 2015-2016Public Health Rep.201813346147110.1177/003335491877725629920225 77.Center for Disease Control and Prevention" exact="Zika" post="Virus TreatmentAvailable online: https://www.cdc.gov/zika/symptoms/treatment.html(accessed on 23 January 2019) 78.collab:"/>
  <result pre="al.High-Content Screening in hPSC-Neural Progenitors Identifies Drug Candidates that Inhibit" exact="Zika" post="Virus Infection in Fetal-like Organoids and Adult BrainCell Stem"/>
  <result pre="azithromycinProc. Natl. Acad. Sci. USA2016113144081441310.1073/pnas.161802911327911847 83.WuY.H.TsengC.K.LinC.K.WeiC.K.LeeJ.C.YoungK.C.ICR suckling mouse model of" exact="Zika" post="virus infection for disease modeling and drug validationPLoS Negl."/>
  <result pre="Negl. Trop. Dis.201812e000684810.1371/journal.pntd.000684830356305 84.DelvecchioR.HigaL.PezzutoP.ValadãoA.GarcezP.MonteiroF.LoiolaE.DiasA.SilvaF.AliotaM.et al.Chloroquine, an Endocytosis Blocking Agent, Inhibits" exact="Zika" post="Virus Infection in Different Cell ModelsViruses2016832210.3390/v8120322 85.ShiryaevS.A.MesciP.PintoA.FernandesI.SheetsN.ShrestaS.FarhyC.HuangC.-T.StronginA.Y.MuotriA.R.et al.Repurposing of"/>
  <result pre="Cell ModelsViruses2016832210.3390/v8120322 85.ShiryaevS.A.MesciP.PintoA.FernandesI.SheetsN.ShrestaS.FarhyC.HuangC.-T.StronginA.Y.MuotriA.R.et al.Repurposing of the anti-malaria drug chloroquine for" exact="Zika" post="Virus treatment and prophylaxisSci. Rep.201771577110.1038/s41598-017-15467-629150641 86.LiC.ZhuX.JiX.QuanquinN.DengY.-Q.TianM.AliyariR.ZuoX.YuanL.AfridiS.K.et al.Chloroquine, a FDA-approved"/>
  <result pre="treatment and prophylaxisSci. Rep.201771577110.1038/s41598-017-15467-629150641 86.LiC.ZhuX.JiX.QuanquinN.DengY.-Q.TianM.AliyariR.ZuoX.YuanL.AfridiS.K.et al.Chloroquine, a FDA-approved Drug, Prevents" exact="Zika" post="Virus Infection and its Associated Congenital Microcephaly in MiceEBioMedicine20172418919410.1016/j.ebiom.2017.09.03429033372"/>
  <result pre="Congenital Microcephaly in MiceEBioMedicine20172418919410.1016/j.ebiom.2017.09.03429033372 87.XuM.LeeE.M.WenZ.ChengY.HuangW.QianX.TcwJ.KouznetsovaJ.OgdenS.C.HammackC.et al.Identification of small-molecule inhibitors of" exact="Zika" post="virus infection and induced neural cell death via a"/>
  <result pre="screenNat. Med.2016221101110710.1038/nm.418427571349 88.BazM.GoyetteN.GriffinB.D.KobingerG.P.BoivinG.In vitro susceptibility of geographically and temporally distinct" exact="Zika" post="viruses to favipiravir and ribavirinAntivir. Ther.20172261361810.3851/IMP318028694390 89.CaiL.SunY.SongY.XuL.BeiZ.ZhangD.DouY.WangH.Viral polymerase inhibitors"/>
  <result pre="89.CaiL.SunY.SongY.XuL.BeiZ.ZhangD.DouY.WangH.Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of" exact="Zika" post="virus replicationArch. Virol.20171622847285310.1007/s00705-017-3436-828597088 90.LankoK.EggermontK.PatelA.KapteinS.DelangL.VerfaillieC.M.NeytsJ.Replication of the Zika virus in"/>
  <result pre="potential inhibitors of Zika virus replicationArch. Virol.20171622847285310.1007/s00705-017-3436-828597088 90.LankoK.EggermontK.PatelA.KapteinS.DelangL.VerfaillieC.M.NeytsJ.Replication of the" exact="Zika" post="virus in different iPSC-derived neuronal cells and implications to"/>
  <result pre="modelsViruses2018107210.3390/v1002007229425176 92.JulanderJ.G.SiddharthanV.EvansJ.TaylorR.TolbertK.ApuliC.StewartJ.CollinsP.GebreM.NeilsonS.et al.Efficacy of the broad-spectrum antiviral compound BCX4430 against" exact="Zika" post="virus in cell culture and in a mouse modelAntivir."/>
  <result pre="Direct-Acting Antiviral Drug, Abrogates Viremia in Rhesus Macaques Challenged with" exact="Zika" post="VirusOpen Forum Infectious Diseases201610.1093/ofid/ofw195.05 94.CostaV.V.Del SartoJ.L.RochaR.F.SilvaF.R.DoriaJ.G.OlmoI.G.MarquesR.E.Queiroz-JuniorC.M.FoureauxG.AraújoJ.M.S.et al.N-Methyl-d-Aspartate (NMDA) Receptor"/>
  <result pre="SartoJ.L.RochaR.F.SilvaF.R.DoriaJ.G.OlmoI.G.MarquesR.E.Queiroz-JuniorC.M.FoureauxG.AraújoJ.M.S.et al.N-Methyl-d-Aspartate (NMDA) Receptor Blockade Prevents Neuronal Death Induced by" exact="Zika" post="Virus InfectionMBio20178e00350-1710.1128/mBio.00350-1728442607 95.CairnsD.M.BoorguD.S.S.K.LevinM.KaplanD.L.Niclosamide rescues microcephaly in a humanized in"/>
  <result pre="95.CairnsD.M.BoorguD.S.S.K.LevinM.KaplanD.L.Niclosamide rescues microcephaly in a humanized in vitro model of" exact="Zika" post="infection using human induced neural stem cellsBiol. Open20187bio03180710.1242/bio.03180729378701 96.DengY.ZhangN.LiC.TianM.HaoJ.XieX.-P.ShiP.-Y.QinC.-F.Adenosine"/>
  <result pre="cellsBiol. Open20187bio03180710.1242/bio.03180729378701 96.DengY.ZhangN.LiC.TianM.HaoJ.XieX.-P.ShiP.-Y.QinC.-F.Adenosine Analog NITD008 Is a Potent Inhibitor of" exact="Zika" post="VirusOpen Forum Infect. Dis.20163ofw17510.1093/ofid/ofw17527747251 97.AdcockR.S.ChuY.K.GoldenJ.E.ChungD.H.Evaluation of anti-Zika virus activities"/>
  <result pre="of dengue virusProc. Natl. Acad. Sci. USA2009106204352043910.1073/pnas.090701010619918064 99.KamiyamaN.SomaR.HidanoS.WatanabeK.UmekitaH.FukudaC.NoguchiK.GendoY.OzakiT.SonodaA.et al.Ribavirin inhibits" exact="Zika" post="virus (ZIKV) replication in vitro and suppresses viremia in"/>
  <result pre="Cells and Radial GliaCell Rep.2016162576259210.1016/j.celrep.2016.08.03827568284 102.Bullard-FeibelmanK.M.GoveroJ.ZhuZ.SalazarV.VeselinovicM.DiamondM.S.GeissB.J.The FDA-approved drug sofosbuvir inhibits" exact="Zika" post="virus infectionAntiviral Res.201713713414010.1016/j.antiviral.2016.11.02327902933 103.SacramentoC.Q.De MeloG.R.De FreitasC.S.RochaN.HoelzL.V.B.MirandaM.Fintelman-RodriguesN.MarttorelliA.FerreiraA.C.Barbosa-LimaG.et al.The clinically approved"/>
  <result pre="103.SacramentoC.Q.De MeloG.R.De FreitasC.S.RochaN.HoelzL.V.B.MirandaM.Fintelman-RodriguesN.MarttorelliA.FerreiraA.C.Barbosa-LimaG.et al.The clinically approved antiviral drug sofosbuvir inhibits" exact="Zika" post="virus replicationSci. Rep.201774092010.1038/srep4092028098253 104.YuY.DengY.Q.ZouP.WangQ.DaiY.YuF.DuL.ZhangN.N.TianM.HaoJ.N.et al.A peptide-based viral inactivator inhibits"/>
  <result pre="Zika virus replicationSci. Rep.201774092010.1038/srep4092028098253 104.YuY.DengY.Q.ZouP.WangQ.DaiY.YuF.DuL.ZhangN.N.TianM.HaoJ.N.et al.A peptide-based viral inactivator inhibits" exact="Zika" post="virus infection in pregnant mice and fetusesNat. Commun.201781567210.1038/ncomms1567228742068 105.SnyderB.GoebelS.KoideF.PtakR.KalkeriR.Synergistic"/>
  <result pre="activity of Sofosbuvir and type-I interferons (α and β) against" exact="Zika" post="virusJ. Med. Virol.20189081210.1002/jmv.2493228851097 106.ChappellC.collab: Gilead Sciencescollab: University of NebraskaStudy"/>
  <result pre="March 2019) 107.WiwanitkitS.WiwanitkitV.Doubled dosage of sofosbuvir is expected for inhibiting" exact="Zika" post="virus infectionAsian Pac. J. Trop. Med.20171061261310.1016/j.apjtm.2017.06.01228756928 108.collab: Gilead Sciences"/>
  <result pre="Res.2016130464910.1016/j.antiviral.2016.03.01327016316 133.EyerL.ZouharováD.ŠirmarováJ.FojtíkováM.ŠtefánikM.HaviernikJ.NenckaR.de ClercqE.RůžekD.Antiviral activity of the adenosine analogue BCX4430 against" exact="West Nile" post="virus and tick-borne flavivirusesAntivir. Res.2017142636710.1016/j.antiviral.2017.03.01228336346 134.collab: BioCryst PharmaceuticalsA Study"/>
  <result pre="Assay for Assessing the Antiviral Activity of Small-Molecule Inhibitors Targeting" exact="Zika" post="VirusAntimicrob. Agents Chemother.201862e00725-1810.1128/AAC.00725-1830061280 136.collab: FDACopegus Packet InsertFDASilver Spring, MD,"/>
  <result pre="USA2011 137.LeonardiW.ZilbermintzL.ChengL.W.ZozayaJ.TranS.H.ElliottJ.H.PolukhinaK.ManasherobR.LiA.ChiX.et al.Bithionol blocks pathogenicity of bacterial toxins, ricin, and" exact="Zika" post="virusSci. Rep.201663447510.1038/srep3447527686742 138.RoyA.LimL.SrivastavaS.LuY.SongJ.Solution conformations of Zika NS2B-NS3pro and its"/>
  <result pre="bacterial toxins, ricin, and Zika virusSci. Rep.201663447510.1038/srep3447527686742 138.RoyA.LimL.SrivastavaS.LuY.SongJ.Solution conformations of" exact="Zika" post="NS2B-NS3pro and its inhibition by natural products from edible"/>
  <result pre="update: Improved access to chemical dataNucleic Acids Res.201947D1102D110910.1093/nar/gky103330371825 Figure 1" exact="Zika" post="virus (ZIKV) infection is associated to late detrimental effects"/>
  <result pre="late detrimental effects to the developing and mature nervous systems." exact="ZIKV" post="infection during the perinatal period (a) and in adult"/>
  <result pre="to ZIKV. pharmaceuticals-12-00060-t001_Table 1Table 1 Drug Candidates for management of" exact="ZIKV" post="infection and its late neurologic complications. Drug Proposed Mechanism"/>
  <result pre="Drug Administration (FDA) Approved? FDA Category Refs. Amodiaquine Unknown for" exact="ZIKV" post="(antimalarial) Vero cell linehuman pluripotent stem cell-derived neural progenitors"/>
  <result pre="to adult SCID-beige mice Discontinued - [80,81] Azithromycin Unknown for" exact="ZIKV" post="(antibiotic) U87 glial cell line 10 mg/kg i.p.to neonatal"/>
  <result pre="i.p.to neonatal ICR mice Yes B [82,83] Chloroquine Unknown for" exact="ZIKV" post="(antimalarial) human neural progenitor cellshuman brain microvascular endothelial cellsmouse"/>
  <result pre="- [104] B.i.d.: bis in die (twice a day); ZIKV:" exact="Zika" post="virus; s.c.: subcutaneous; i.m. intramuscular; i.p.: intraperitoneal; p.o.: per"/>
 </snippets>
</snippetsTree>
